Another Novartis failure; Novo drops the ‘Nordisk’; and more

Welcome back to another edition of Endpoints Weekly! We’ll get to the headlines in just a bit, but be sure to check out the recordings of our China event in ... Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and…

Source: Endpoints News